Fecal Virome Transplantation (FVT) has in small studies shown benefit in the treatment of recurrent C. difficile infection.
In the VISION study we will treat patients with recurrent C. difficile infection with FVT capsules and compare the treatment with Fecal Microbiota Transplantation (FMT) capsules. Both will be following af standard treatment of antibiotics (Vancomycin)
Recurrent C. difficile infection (first or second recurrence)
Understand danish
Serious food allergy (anaphylaxis)
Other pathogenic bacteria/virus in stool sample prior to inclusion
Inability to ingest capsules
Gastrointestinal perforation in the 180 days prior to inclusion
Copenhagen University Hospital, Hvidovre
Lead sponsor
University of Copenhagen
Collaborator